Learn More
Cayman Chemical ParItaprevIr 10mg

Supplier: Cayman Chemical 2830110 MG
An orally bioavailable, direct-acting inhibitor of HCV NS3/4A serine protease; inhibits HCV replication in stable Huh7-derived replicon cell lines infected with subgenomic genotypes 1a, 1b, 2a, 3a, 4a, and 6a (EC50s = 1, 0.21, 5.3, 19, 0.09, and 0.69 nM, respectively); inhibits replicons from clinical isolates of genotypes 1a (EC50s = 0.43 to 1.87 nM) and 1b (EC50s = 0.033 to 0.087 nM)
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.